ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Home-based treatment for patients with hematological cancer in Denmark-A national overview.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Bringing the hospital home: exploring the challenges and perspectives of healthcare professionals on home treatment in hemato-oncology: a qualitative analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
- A Scoping Review of Implemented Innovations in Cancer Care: Implications for Pan-Canadian Scaling.Current oncology (Toronto, Ont.) · 2026Article
- HIV-Associated Diffuse Large B-Cell Lymphoma Treated With Outpatient Pola-R-CHP Without Antiretroviral Therapy Modification: A Case Report.Case reports in infectious diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeTo investigate the extent and practice of home-based treatment for patients with hematologic malignancies in Denmark.
methodsThis nationwide exploratory study was conducted at all Danish hematologic departments (n = 9). Each site received an online questionnaire for the collection of data on the type of therapy administered as home-based treatment, the specific treatments with details on target populations, patient criteria, implementation status, and practice for clinical management.
resultsSix types of therapy were offered as home-based treatments across the Danish hematologic departments: chemotherapy, immunoglobulin, immunotherapy, hydration therapy, antibiotics, and parenteral nutrition. In total, 17 treatments were offered, with the majority being provided to patients with multiple myeloma. Immunoglobulin and antibiotics were most often provided at home. Variations were identified regarding patient criteria for receiving home-based treatment, including personal resources and social networks, use of intravenous accesses and infusion pumps, and timing of initiation of home-based treatment.
conclusionThere is variation in the implementation of home-based treatment for patients with hematologic malignancies in Denmark, including different criteria and practices. To fully realize the benefits of home-based treatment, it is imperative to address access disparities, standardize practices, and enhance support for patients and caregivers. Continued research, collaboration, and policy development are essential to ensure that all patients have equitable access to high-quality home-based treatment options.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.